Discover and read the best of Twitter Threads about #generalsurgery
Most recents (3)
1/π§΅for my #GeneralSurgery folks.
@AmBdSurg oral boards is probably the toughest exam you will face in your career (definitely was for me)!
I couldn't find really good guidance anywhere when I was a resident.
I got #boardcertified within 4 months of graduation,π is how to do it!
@AmBdSurg oral boards is probably the toughest exam you will face in your career (definitely was for me)!
I couldn't find really good guidance anywhere when I was a resident.
I got #boardcertified within 4 months of graduation,π is how to do it!
2/Good @AmBdSurg CE preparation starts with a good preparation for the @AmBdSurg QE!
This π is how I studied for the QE:
Read Cameron in PGY-4
In PGY-5:
@SCOREsurg Qs
@SESAP_ Qs
Operative dictations in GS book
Dimicks common scenario book
After graduation:
@TrueLearnLLC Qs
This π is how I studied for the QE:
Read Cameron in PGY-4
In PGY-5:
@SCOREsurg Qs
@SESAP_ Qs
Operative dictations in GS book
Dimicks common scenario book
After graduation:
@TrueLearnLLC Qs
1/n) ICMR released Standard Treatment Workflows (STWs) volume 3 which contains 11 specialties with 52 diseases. It is accessible at stw.icmr.org.in/stws and on the Mobile App.
@MoHFW_INDIA @DeptHealthRes #STW
@MoHFW_INDIA @DeptHealthRes #STW
2/n) Standard Treatment Workflows (STWs) on #πππ«π¦πππ¨π₯π¨π π² containing 14 major diseases. It is accessible at stw.icmr.org.in/stws and on the Mobile App. @MoHFW_INDIA @DeptHealthRes
3/n) Standard Treatment Workflows (STWs) on #Endocrinology containing 06 major diseases. It is accessible at stw.icmr.org.in/stws and on the Mobile App. @MoHFW_INDIA @AyushmanNHA @WHOSEARO #diabetes
We proudly share the first @CovidSurg @GlobalSurg paper published in @Anaes_Journal based on the worldβs biggest data about surgery following SARS-CoV-2 infection. Hopefully, it will guide practice.
πIt is open access and you can read it here π doi.org/10.1111/anae.1β¦
πIt is open access and you can read it here π doi.org/10.1111/anae.1β¦
@CovidSurg @GlobalSurg Week was an international, prospective cohort study with more than 140,000 surgical patients from 116 countries enrolled πππ
We compared 30-day postoperative mortality in previously infected patients with SARS-CoV-2 vs patients who never were infected
We compared 30-day postoperative mortality in previously infected patients with SARS-CoV-2 vs patients who never were infected
Previously infected patients having surgery at 0-2, 3-4, 5-6 weeks after the infection have higher mortality rates than patients who never got infected with SARS-CoV-2
